Cribstone Capital Management »

Ishares Tr genomics immun shares owned by Cribstone Capital Management

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Cribstone Capital Management from 13F filings

Historical chart of Cribstone Capital Management investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Cribstone Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Cribstone Capital Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $18k 700 25.17

More positions owned by Cribstone Capital Management

Technology Select Sector SPDRR ETF Ef (XLK)
Spdr Gold Shares Etf Ef (GLD)
Select Str Financial Ef (XLF)
Spdr Doubleline Ttl Rtrn Ef (TOTL)
Apple CS (AAPL)
Spdr Fund Consumer Ef (XLY)
Vanguard FTSE Developed Markets ETF Ef (VEA)
iShares iBonds Dec 2025 Term Corp ETF Ef (IBDQ)
iShares iBonds Dec 2023 Term Corp ETF Ef
iShares iBonds Dec 2024 Term Corp ETF Ef
Microsoft Corp CS (MSFT)
Spdrr S&p 500 Etf Ef (SPY)
iShares iBonds Dec 2028 Term Corp ETF Ef (IBDT)
Ishares Msci Kld 400 Ef (DSI)
Alphabet Inc A CS (GOOGL)

View all positions for Cribstone Capital Management

Top funds holding Ishares Tr genomics immun

UBS Group
Bank of America Corporation
Wharton Business Group
Royal Bank of Canada
Ameriprise Financial
Bsc Private Wealth Management
Cora Capital Advisors
LPL Financial
Commonwealth Equity Services
Susquehanna International
Carnick & Kubik
Visionary Wealth Advisors
Advisor Group Holdings
Nelson, Van Denburg & Campbell Wealth Management
Raymond James Financial Services Advisors

View all funds holding Ishares Tr genomics immun